Ticker: TBPH

Theravance Biopharma, Inc. (NASDAQ: TBPH) - quick take What's happening inside the company * Management completed a strategic monetization: sale of remaining TRELEGY royalty rights to GSK for $225,000 (cash received June 27, 2025). The transaction generated a reported net gain of $75,137 for the ...